Pharmaceutical intermediates
Ketorolac tromethamine Intermediates
2 pharmaceutical intermediates for Ketorolac tromethamine. Indication: Inflammatory disease; Bite wound; Burn; Acute pain; Allergic conjunctivitis; Postoperative inflammation.
About Ketorolac tromethamine
- Originator
- Roche Palo Alto Llc
- Indication
- Inflammatory disease; Bite wound; Burn; Acute pain; Allergic conjunctivitis; Postoperative inflammation
- Approved Date
- 11/30/1989
Available intermediates
2 intermediates currently listed for Ketorolac tromethamine. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| Ketorolac tromethamine | 74103-07-4 | / | / |
| 2-Benzoylpyrrole | 7697-46-3 | / | / |
Other programs under K
Building toward Ketorolac tromethamine?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →